X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (4008) 4008
Publication (267) 267
Book Review (49) 49
Magazine Article (24) 24
Book Chapter (20) 20
Newsletter (15) 15
Newspaper Article (8) 8
Book / eBook (4) 4
Trade Publication Article (2) 2
Conference Proceeding (1) 1
Data Set (1) 1
Dissertation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (3622) 3622
female (2024) 2024
male (1934) 1934
cephalosporins - adverse effects (1895) 1895
cephalosporins - therapeutic use (1804) 1804
adult (1364) 1364
middle aged (1262) 1262
aged (1103) 1103
cephalosporins (839) 839
anti-bacterial agents - adverse effects (815) 815
anti-bacterial agents - therapeutic use (786) 786
cephalosporins - administration & dosage (771) 771
index medicus (763) 763
adolescent (700) 700
child (673) 673
bacterial infections - drug therapy (653) 653
pharmacology & pharmacy (604) 604
antibiotics (588) 588
child, preschool (509) 509
infectious diseases (465) 465
infant (454) 454
cephalosporins - pharmacology (414) 414
anti-bacterial agents - administration & dosage (396) 396
treatment outcome (378) 378
microbiology (362) 362
microbial sensitivity tests (358) 358
penicillins - adverse effects (350) 350
aged, 80 and over (333) 333
animals (333) 333
infections (310) 310
moxalactam (310) 310
urinary tract infections - drug therapy (296) 296
risk factors (281) 281
cephalosporins - pharmacokinetics (278) 278
cephalosporin (275) 275
immunology (265) 265
prospective studies (262) 262
penicillin (257) 257
drug evaluation (247) 247
retrospective studies (245) 245
bacteria - drug effects (235) 235
medicine, general & internal (235) 235
cephaloridine (229) 229
respiratory tract infections - drug therapy (226) 226
allergy (223) 223
clinical trials as topic (222) 222
drug resistance, microbial (217) 217
administration, oral (212) 212
pediatrics (203) 203
acute disease (200) 200
bacterial infections - microbiology (182) 182
anti-bacterial agents - pharmacology (181) 181
drug therapy, combination (180) 180
drug therapy (179) 179
cefepime (178) 178
penicillins - therapeutic use (178) 178
drug hypersensitivity - etiology (175) 175
injections, intravenous (170) 170
double-blind method (169) 169
health aspects (169) 169
therapy (166) 166
time factors (165) 165
ceftazidime (164) 164
children (159) 159
cephalosporins - metabolism (157) 157
skin tests (156) 156
research article (151) 151
staphylococcal infections - drug therapy (151) 151
pharmacokinetics (148) 148
ceftriaxone (147) 147
drug hypersensitivity - diagnosis (143) 143
infant, newborn (141) 141
pregnancy (141) 141
research (137) 137
ceftriaxone - adverse effects (135) 135
drug administration schedule (135) 135
surgery (134) 134
antibiotic prophylaxis (128) 128
cefuroxime - therapeutic use (126) 126
cross-reactivity (126) 126
anti-bacterial agents - pharmacokinetics (125) 125
infection (125) 125
beta-lactam antibiotics (123) 123
surgical wound infection - prevention & control (123) 123
age factors (120) 120
pneumonia (120) 120
young adult (120) 120
oncology (119) 119
bacteria (118) 118
cefazolin - therapeutic use (114) 114
cefuroxime - adverse effects (114) 114
diagnosis (114) 114
vancomycin - therapeutic use (114) 114
care and treatment (112) 112
medicine & public health (111) 111
epidemiology (110) 110
antimicrobial agents (109) 109
drug resistance (109) 109
analysis (108) 108
ceftriaxone - therapeutic use (107) 107
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3346) 3346
Japanese (344) 344
German (104) 104
French (88) 88
Spanish (50) 50
Russian (43) 43
Italian (25) 25
Chinese (15) 15
Polish (13) 13
Dutch (9) 9
Swedish (8) 8
Hungarian (6) 6
Czech (5) 5
Portuguese (5) 5
Bulgarian (4) 4
Danish (3) 3
Romanian (2) 2
Finnish (1) 1
Hebrew (1) 1
Icelandic (1) 1
Korean (1) 1
Norwegian (1) 1
Serbian (1) 1
Slovak (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Cancer, ISSN 0008-543X, 07/2014, Volume 120, Issue 13, pp. 1985 - 1992
BACKGROUND Intensive chemotherapy for pediatric acute myeloid leukemia incurs the risk of infectious complications, but the benefits of antibiotic prophylaxis... 
infection | acute myeloid leukemia | children | antibiotics | prophylaxis | MORTALITY | PEDIATRIC ONCOLOGY PATIENTS | CANCER | CHEMOTHERAPY | TRIAL | INTENSIVE TREATMENT | THERAPY | ONCOLOGY | BACTERIAL-INFECTION | MINIMAL RESIDUAL DISEASE | EPIDEMIOLOGY | Humans | Chemotherapy-Induced Febrile Neutropenia - prevention & control | Child, Preschool | Infant | Male | Antibiotic Prophylaxis - adverse effects | Candidiasis - diagnosis | Feasibility Studies | Incidence | Outpatients - statistics & numerical data | Bacteremia - microbiology | Young Adult | Anti-Bacterial Agents - therapeutic use | Bacteremia - prevention & control | Leukemia, Myeloid, Acute - drug therapy | Female | Anti-Bacterial Agents - adverse effects | Retrospective Studies | Drug Therapy, Combination | Child | Antibiotic Prophylaxis - utilization | Bacterial Infections - microbiology | Rectum - microbiology | Vancomycin - administration & dosage | Administration, Oral | Leukemia, Myeloid, Acute - pathology | Antibiotic Prophylaxis - methods | Treatment Outcome | Cephalosporins - administration & dosage | Induction Chemotherapy - adverse effects | Bacterial Infections - prevention & control | Ciprofloxacin - administration & dosage | Adolescent | Bacterial Infections - epidemiology | Antibiotic Prophylaxis - trends | Infusions, Intravenous | Nose - microbiology | Consolidation Chemotherapy - adverse effects | Neoplasm Staging | Anti-Bacterial Agents - administration & dosage | Antibacterial agents | Usage | Patient outcomes | Index Medicus | Abridged Index Medicus
Journal Article
Journal Article
Journal of Allergy and Clinical Immunology, The, ISSN 0091-6749, 2010, Volume 125, Issue 2, pp. S126 - S137.e1
Drug allergy is one type of adverse reaction to drugs and encompasses a spectrum of hypersensitivity reactions with heterogeneous mechanisms and clinical... 
Allergy and Immunology | penicillin | graded challenge | angiotensin-converting enzyme inhibitors | radiocontrast media | cephalosporin | desensitization | Drug allergy | biologic modifiers | adverse drug reactions | carbapenem | local anesthetic | sulfonamide | drug hypersensitivity | tolerance | nonsteroidal anti-inflammatory drug | HOSPITALIZED-PATIENTS | CONVERTING ENZYME-INHIBITORS | IMMUNOLOGY | ANGIOTENSIN RECEPTOR BLOCKERS | ALLERGY | CROSS-REACTIVITY | PENICILLIN ALLERGY | IGE-MEDIATED HYPERSENSITIVITY | ADVERSE-REACTIONS | IODINATED CONTRAST-MEDIA | IMMEDIATE HYPERSENSITIVITY | BETA-LACTAM ANTIBIOTICS | Medical History Taking | Anti-HIV Agents - adverse effects | Humans | Drug Hypersensitivity - therapy | Anti-Inflammatory Agents, Non-Steroidal - adverse effects | Contrast Media - adverse effects | Antineoplastic Agents - adverse effects | Angiotensin-Converting Enzyme Inhibitors - adverse effects | Drug Hypersensitivity - diagnosis | beta-Lactams - adverse effects | Drug-Related Side Effects and Adverse Reactions - physiopathology | Drug Hypersensitivity - physiopathology | Drug-Related Side Effects and Adverse Reactions - diagnosis | Drug-Related Side Effects and Adverse Reactions - therapy | Lupus | Allergy | Enzymes | Aspirin | Sulfonamides | Beta lactam antibiotics | Respiratory tract diseases | Salicylates | Drug therapy | Anesthetics | Allergic reaction | Nonsteroidal anti-inflammatory drugs | Drug dosages | Patients | Management decisions | Allergies | Penicillin
Journal Article
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, ISSN 0098-7484, 09/2018, Volume 320, Issue 10, pp. 984 - 994
IMPORTANCE Extended-spectrum beta-lactamases mediate resistance to third-generation cephalosporins (eg, ceftriaxone) in Escherichia coli and Klebsiella... 
UNITED-STATES | MEDICINE, GENERAL & INTERNAL | EXTENDED-SPECTRUM | CEFEPIME | THERAPY | BACTEREMIA | LACTAMASE-PRODUCING ENTEROBACTERIACEAE | SPECTRUM BETA-LACTAMASES | EXTENSION | Escherichia coli Infections - mortality | Klebsiella pneumoniae - drug effects | Escherichia coli - drug effects | Humans | Middle Aged | Drug Resistance, Bacterial | Bacteremia - mortality | Ceftriaxone - pharmacology | Male | Cause of Death | Anti-Bacterial Agents - therapeutic use | Penicillanic Acid - therapeutic use | Adult | Female | Anti-Bacterial Agents - adverse effects | Meropenem | Penicillanic Acid - adverse effects | Thienamycins - adverse effects | Penicillanic Acid - analogs & derivatives | Thienamycins - therapeutic use | Escherichia coli Infections - drug therapy | Klebsiella Infections - drug therapy | Piperacillin, Tazobactam Drug Combination | Bacteremia - drug therapy | Piperacillin - adverse effects | Klebsiella Infections - mortality | Aged | Anti-Bacterial Agents - pharmacology | Piperacillin - therapeutic use | Klebsiella | Treatment outcome | Safety and security measures | Tazobactam | Escherichia coli | Patient outcomes | Analysis | Comparative analysis | Risk factors | Bacterial infections | Intravenous administration | Mortality | Clinical trials | Piperacillin-tazobactam | Infections | Ceftriaxone | Drug resistance | Patients | Side effects | Randomization | Cephalosporins | E coli | Piperacillin | Drug therapy | Blood diseases | Blood culture | Carbapenems | Original Investigation | Research
Journal Article
Journal Article
Clinical Infectious Diseases, ISSN 1058-4838, 2017, Volume 64, Issue 2, pp. 116 - 123
Journal Article
Lancet, The, ISSN 0140-6736, 2015, Volume 385, Issue 9981, pp. 1949 - 1956
Journal Article
Journal Article